Intellectual disability and autistic behavior and their modifying factors in children with tuberous sclerosis complex
Brain and Development · 2025
DOI: 10.1016/j.braindev.2025.104322 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Development, 2025. Verfasst von Sergiusz Jóźwiak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, The Children's Memorial Health Institute, 04-730 Warsaw, Poland. Electronic address: s.jozwiak@ipczd.pl. Hauptthemen laut MEDLINE: Tuberous Sclerosis, Intellectual Disability, Autistic Disorder. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Medical Research Agency.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Department, The Children's Memorial Health Institute, 04-730 Warsaw, Poland. Electronic address: s.jozwiak@ipczd.pl.
- Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University, 00133 Rome, Italy.
- Department of Neurology and Epileptology, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Förderung
- Medical Research Agency
Zitieren
APA
Jóźwiak, S., Curatolo, P., & Kotulska, K. (2025). Intellectual disability and autistic behavior and their modifying factors in children with tuberous sclerosis complex. Brain and Development. https://doi.org/10.1016/j.braindev.2025.104322
Vancouver
Jóźwiak S, Curatolo P, Kotulska K. Intellectual disability and autistic behavior and their modifying factors in children with tuberous sclerosis complex. Brain and Development. 2025. doi:10.1016/j.braindev.2025.104322
BibTeX
@article{Jwiak2025,
author = {Jóźwiak, Sergiusz and Curatolo, Paolo and Kotulska, Katarzyna},
title = {Intellectual disability and autistic behavior and their modifying factors in children with tuberous sclerosis complex},
journal = {Brain and Development},
year = {2025},
doi = {10.1016/j.braindev.2025.104322}
}
EUVIMED